NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma-Reference-Cited by-同舟云学术

NGS based identification of mutational hotspots for targeted therapy in anaplastic thyroid carcinoma

Published:2017-04-20 Issue:26 Volume:8 Page:42613-42620
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Tiedje Vera¹,Ting Saskia²,Herold Thomas²³,Synoracki Sarah²,Latteyer Soeren¹,Moeller Lars C.¹,Zwanziger Denise¹,Stuschke Martin⁴,Fuehrer Dagmar¹,Schmid Kurt Werner²

Affiliation:

1. Department of Endocrinology and Metabolism, Endocrine Tumour Center at West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg-Essen, Germany

2. Institute of Pathology, University Hospital Essen, University of Duisburg-Essen, Duisburg-Essen, Germany

3. German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany

4. Department of Radiotherapy, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Duisburg-Essen, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schilddrüsenkarzinome – Rolle internistischer Systemtherapien;Die Innere Medizin;2024-06-20

2. Comprehensive genomic profiling from C‐CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1;Clinical Endocrinology;2024-06-09

3. Exploring Emerging Therapeutic Targets and Opportunities in Neuroendocrine Tumors: Updates on Receptor Tyrosine Kinases;Receptors;2024-04-05

4. The genomic and evolutionary landscapes of anaplastic thyroid carcinoma;Cell Reports;2024-03

5. Strategies to investigate migration and metastases in thyroid cancer;Current Opinion in Endocrine and Metabolic Research;2024-03